Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma (RCC) Meeting Abstract

  

Authors:	Lee, C. H.; Wan, Y.; Smith, A. D.; Xie, R.; Motzer, R. J.
Abstract Title:	Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma (RCC)
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Start Page:	293s
Language:	English
ACCESSION:	WOS:000560368302322
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.5067
Notes:	Meeting Abstract: 5067 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/172914